Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Veracyte, Inc. - Common Stock (NQ:VCYT)

38.25 -1.31 (-3.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,107,419
Open 39.10
Bid (Size) 38.25 (5,300)
Ask (Size) 38.26 (1,100)
Prev. Close 39.56
Today's Range 37.66 - 39.37
52wk Range 22.61 - 50.71
Shares Outstanding 67,473,870
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Why Veracyte Stock Is Skyrocketing Higher This Week ↗
Veracyte's first-quarter earnings were excellent, and the company's future looks bright. 
Via The Motley Fool

Performance

YTD
-9.8%
-9.8%
1 Month
+17.9%
+17.9%
3 Month
+3.3%
+3.3%
6 Month
-10.3%
-10.3%
1 Year
+24.3%
+24.3%

More News

Read More
Veracyte Inc (NASDAQ:VCYT) Smashes Q1 Estimates and Raises Full-Year Guidance, Shares Surge ↗
Via Chartmill
News headline image
Veracyte (VCYT) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Veracyte Inc (NASDAQ:VCYT) GARP Analysis Reveals Strong Growth at a Reasonable Price ↗
Via Chartmill
Veracyte Inc (NASDAQ:VCYT): A High-Growth Biotech Stock Poised for a Technical Breakout ↗
Via Chartmill
Veracyte Inc (NASDAQ:VCYT) Emerges as a Prime Growth at a Reasonable Price (GARP) Candidate ↗
Via Chartmill
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill
News headline image
Veracyte Announces First Quarter 2026 Financial Results
From Veracyte, Inc.
Via Business Wire
News headline image
Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers
From Veracyte, Inc.
Via Business Wire
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
Via Chartmill
Veracyte Inc (NASDAQ:VCYT) Posts Strong Q4 Earnings Beat and Positive 2026 Outlook ↗
Via Chartmill
Topics Earnings
Veracyte Inc (NASDAQ:VCYT): A Prime GARP Stock with Strong Growth and a Sound Balance Sheet ↗
Via Chartmill
News headline image
Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026
From Veracyte, Inc.
Via Business Wire
News headline image
Veracyte Names Kevin Haas as Chief Development and Technology Officer
From Veracyte, Inc.
Via Business Wire
News headline image
Veracyte (VCYT) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Veracyte Inc. (NASDAQ:VCYT) Emerges as a Prime Affordable Growth Candidate ↗
Via Chartmill
News headline image
Veracyte Announces Fourth Quarter and Full Year 2025 Financial Results
From Veracyte, Inc.
Via Business Wire
News headline image
Veracyte to Highlight Extensive Decipher® Data at 2026 ASCO GU Symposium
From Veracyte
Via Business Wire
News headline image
Veracyte to Participate in Upcoming Investor Conferences
From Veracyte, Inc.
Via Business Wire
News headline image
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
From Veracyte, Inc.
Via Business Wire
News headline image
Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability
Via MarketMinute
Topics Artificial Intelligence Death
News headline image
Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results
From Veracyte, Inc.
Via Business Wire
News headline image
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Veracyte, Inc.
Via Business Wire
News headline image
Veracyte Inc (NASDAQ:VCYT) Emerges as a Top Affordable Growth Stock ↗
Via Chartmill

Frequently Asked Questions

Is Veracyte, Inc. - Common Stock publicly traded?
Yes, Veracyte, Inc. - Common Stock is publicly traded.
What exchange does Veracyte, Inc. - Common Stock trade on?
Veracyte, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Veracyte, Inc. - Common Stock?
The ticker symbol for Veracyte, Inc. - Common Stock is VCYT on the Nasdaq Stock Market
What is the current price of Veracyte, Inc. - Common Stock?
The current price of Veracyte, Inc. - Common Stock is 38.25
When was Veracyte, Inc. - Common Stock last traded?
The last trade of Veracyte, Inc. - Common Stock was at 05/13/26 04:00 PM ET
What is the market capitalization of Veracyte, Inc. - Common Stock?
The market capitalization of Veracyte, Inc. - Common Stock is 2.58B
How many shares of Veracyte, Inc. - Common Stock are outstanding?
Veracyte, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.